Introduction to Antimicrobial Therapeutics Reviews: The bacterial cell wall as an antimicrobial target

Annals of the New York Academy of Sciences

Volumn 1277, Issue 1, 2013, Pages 5-7

  Bush, Karen ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM; CEPHALOSPORIN; DAPTOMYCIN; GLYCOPEPTIDE; MONOBACTAM DERIVATIVE; NATURAL PRODUCT; PENICILLIN DERIVATIVE; PEPTIDOGLYCAN; SIDEROPHORE; VANCOMYCIN;

ARTICLE; BACTERIAL CELL WALL; BIOSYNTHESIS; CELL DIVISION; DRUG EFFICACY; DRUG SAFETY; IRON TRANSPORT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; BACTERIUM; CELL WALL; DRUG EFFECT; EDITORIAL; HUMAN; METABOLISM;

ANTI-BACTERIAL AGENTS; BACTERIA; CELL WALL; HUMANS;

MLCS; MLOWN;

EID: 84872854003     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/nyas.12025     Document Type: Article

References (15)

1. Duemling, W.W. 1946. Clinical experiences with penicillin in the Navy. Ann. N. Y. Acad. Sci. 48: 201-218.
2. Stansly, P.G., R.G. Shepherd & H.J. White 1947. Polymyxin: a new chemotherapeutic agent. Bull. Johns Hopkins Hosp. 81: 43-54.
3. Livermore, D.M. 2009. Has the era of untreatable infections arrived J. Antimicrob. Chemother. 64(Suppl 1): i29-36.
4. Master, R.N., J. Deane, C. Opiela & D.F. Sahm 2013. Recent trends in resistance to cell envelope-active antibacterial agents among key bacterial pathogens. Ann. N. Y. Acad. Sci. 1277: 1-7. This volume.
5. Egan, A.J.F. & W. Vollmer 2013. The physiology of bacterial cell division. Ann. N. Y. Acad. Sci. 1277: 8-28. This volume.
6. Silver, L.L. 2013. Viable screening targets related to the bacterial cell wall. Ann. N. Y. Acad. Sci. 1277: 29-53. This volume.
7. Johnson, J.W., J.F. Fisher & S. Mobashery 2013. Bacterial cell-wall recycling. Ann. N. Y. Acad. Sci. 1277: 54-75. This volume.
8. Crandon, J.L. & D.P. Nicolau 2011. Pharmacodynamic approaches to optimizing beta-lactam therapy. Crit. Care Clinics. 27: 77-93.
9. Talbot, G.H. 2013. β-lactam antimicrobials: what have you done for me lately Ann. N. Y. Acad. Sci. 1277: 76-83. This volume.
10. Bush. K. 2013. Proliferation and significance of clinically relevant β-lactamases. Ann. N. Y. Acad. Sci. 1277: 84-90. This volume.
11. Palzkill, T. 2013. Metallo-β-lactamase structure and function. Ann. N. Y. Acad. Sci. 1277: 91-104. This volume.
12. Shlaes, D.M. 2013. New β-lactam-β-lactamase inhibitor combinations in clinical development. Ann. N. Y. Acad. Sci. 1277: 105-114. This volume.
13. Page, M.G.P. 2013. Siderophore conjugates. Ann. N.Y. Acad. Sci. 1277: 115-126. This volume.
14. Yount, N.Y. & M.R. Yeaman 2013. Peptide antimicrobials: cell wall as a bacterial target. Ann. N. Y. Acad. Sci. 1277: 127-138. This volume.
15. Bayer, A.S., T. Schneider & H.-G. Sahl 2013. Mechanisms of daptomycin resistance in Staphylococcus aureus: role of the cell membrane and cell wall. Ann. N.Y. Acad. Sci. 1277: 139-158. This volume.